Genetic polymorphisms within tumor necrosis factor gene promoter region: A role for susceptibility to ventilator-associated pneumonia

Cytokine

Volumn 59, Issue 2, 2012, Pages 358-363

  Kotsaki, Antigoni ^a   Raftogiannis, Maria ^a   Routsi, Christina ^a   Baziaka, Fotini ^a   Kotanidou, Anastasia ^a   Antonopoulou, Anastasia ^a   Orfanos, Stylianos E ^a   Katsenos, Chrisostomos ^b   Koutoukas, Pantelis ^a   Plachouras, Diamantis ^a   Mandragos, Konstantinos ^b   Giamarellos Bourboulis, Evangelos J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Intensive Care Unit   (Greece)

Author keywords

Cytokines; Genetic polymorphisms; Tumor necrosis factor; Ventilator associated pneumonia

Indexed keywords

ENDOTOXIN; GENOMIC DNA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; ARTIFICIAL VENTILATION; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA EXTRACTION; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; INTERFERON PRODUCTION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR GENE; VENTILATOR ASSOCIATED PNEUMONIA; WILD TYPE;

ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RESPIRATION, ARTIFICIAL; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS);

EID: 84862315907     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.040     Document Type: Article

References (25)

1. Hunter J., Annadurai S., Rothell M. Diagnosis, management and prevention of ventilator-associated pneumonia in the UK. Eur J Anaesthesiol 2010, 24:971-977.
2. Vincent J.L. Ventilator-associated pneumonia. J Hosp Infect 2004, 57:272-280.
3. Namath A., Patterson A.J. Genetic polymorphisms in sepsis. Crit Care Clin 2009, 25:835-856.
4. Pfeffer K. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev 2003, 14:185-191.
5. Casey L.C.B.R., Bone R.C. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993, 119:771-778.
6. Uglialoro A.M., Turbay D., Pesavento P.A., Delgado J.C., McKenzie F.E., Gribben J.G., et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998, 52:359-367.
7. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997, 94:3195-3199.
8. Elahi M.M., Asotra K., Matata B.M., Mastana S.S. Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta 2009, 1792:163-172.
9. Waterer G.W., Quasney M.W., Cantor R.M., Wunderink R.G. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med 2001, 163:1599-1604.
10. Teuffel O., Ethier M.C., Beyene J., Sung L. Association between tumor necrosis factor-alpha promoter -308 A/G polymorphism and susceptibility to sepsis and sepsis mortality: a systematic review and meta-analysis. Crit Care Med 2010, 38:276-282.
11. Rello J., Paiva J.A., Baraibar J., Barcenilla F., Bodi M., Castander D., et al. International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest 2001, 120:955-970.
12. Baughman R.P. Diagnosis of ventilator-associated pneumonia. Curr Opin Crit Care 2003, 9:397-402.
13. Pugin J., Auckenthaler R., Mili N., Janssens J.P., Lew P.D., Suter P.M. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991, 143:1121-1129.
14. Levy M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2001, 31(2003):1250-1256.
15. Lenth RV. Java applets for power and sample size, 2010[accessed 23.04.12]. http://www.stat.uiowa.edu/~rlenth/Power.
16. Giamarellos-Bourboulis E.J., van de Veerdonk F., Mouktaroudi M., Raftogiannis M., Antonopoulou A., Joosten L.A.B., et al. Inhibition of caspase-1 activation in Gram-negative sepsis and experimental endotoxemia. Crit Care 2001, 15:R27.
17. Gallagher P.M., Lowe G., Fitzgerald T., Bella A., Greene C.M., McElvaney N.G., et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 2003, 58:154-156.
18. Reid C.L., Perrey C., Pravica V., Hutchinson I.V., Campbell I.T. Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome. Crit Care Med 2002, 30:2216-2221.
19. Read R.C., Teare D.M., Pridmore A.C., Naylor S.C., Timms J.M., Kaczmarski E.B., et al. The tumor necrosis factor polymorphism TNF (-308) is associated with susceptibility to meningococcal sepsis, but not with lethality. Crit Care Med 2009, 37:1237-1243.
20. Tang G.J., Huang S.L., Yien H.W., Chen W.S., Chi C.W., Wu C.W., et al. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000, 28:2733-2736.
21. O'Keefe G.E., Hybki D.L., Munford R.S. The GA single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. J Trauma 2002, 52:817-825.
22. Barber R.C., Aragaki C.C., Rivera-Chavez F.A., Purdue G.F., Hunt J.L., Horton J.W. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 2004, 41:808-813.
23. Louis E., Franchimont D., Piron A., Gevaert Y., Schaaf-Lafontaine N., Roland S., et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998, 113:401-406.
24. Heesen M., Kunz D., Bachmann-Mennenga B., Merk H.F., Bloemeke B. Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: association with TNF alpha response of granulocytes to endotoxin stimulation. Crit Care Med 2003, 31:211-214.
25. Arcaroli J., Silva E., Maloney J.P., He Q., Svetkauskaite D., Murphy J.R., et al. Variant IRAK-1 haplotype is associated with increased nuclear factor-κB activation and worse outcomes in sepsis. Am J Resp Crit Care Med 2006, 173:1335-1341.